IOVA Archives - Page 12 of 12

2 minute read

Iovance Biotherapeutics Initiates Biologics License Application Submission For Lifileucel In Advanced Melanoma

August 25, 7:38 AM

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, today announced that it has initiated a rolling Biologics License Application (BLA)

IOVA

4 minute read

Options

10 Health Care Stocks Whale Activity In Today’s Session

By Benzinga Insights

August 17, 1:36 PM

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

2 minute read

Analyst Ratings

Expert Ratings for Iovance Biotherapeutics

By Benzinga Insights

August 5, 5:26 PM

Within the last quarter, Iovance Biotherapeutics (NASDAQ:IOVA) has observed the following analyst ratings:

IOVA

1 minute read

Earnings

Iovance Biotherapeutics: Q2 Earnings Insights

By Benzinga Insights

August 4, 5:22 PM

Iovance Biotherapeutics (NASDAQ:IOVA) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

IOVA